PUTNAM INVESTMENTS LLC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 229 filers reported holding ARRAY BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
PUTNAM INVESTMENTS LLC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$5,142,000
+8.3%
110,987
-43.0%
0.01%0.0%
Q1 2019$4,749,000
+71.1%
194,7830.0%0.01%
+57.1%
Q4 2018$2,776,000
-6.2%
194,7830.0%0.01%
+16.7%
Q3 2018$2,960,000
-37.6%
194,783
-31.0%
0.01%
+20.0%
Q2 2018$4,740,000
+107.4%
282,398
+101.7%
0.01%0.0%
Q1 2018$2,285,000
-70.2%
140,004
-76.7%
0.01%
-44.4%
Q4 2017$7,680,000
+83.6%
600,056
+76.4%
0.01%
-10.0%
Q3 2017$4,184,000
-37.8%
340,168
-57.7%
0.01%
-37.5%
Q2 2017$6,730,000
+28.5%
804,009
+37.3%
0.02%
+33.3%
Q1 2017$5,236,000
+163.9%
585,702
+159.4%
0.01%
+140.0%
Q4 2016$1,984,000
+118.0%
225,763
+67.4%
0.01%
+150.0%
Q3 2016$910,000
-0.7%
134,841
-30.3%
0.00%0.0%
Q4 2014$916,000
+31.8%
193,585
-0.6%
0.00%
+100.0%
Q3 2014$695,000
-20.2%
194,707
+2.0%
0.00%
-50.0%
Q2 2014$871,000
-2.9%
190,981
+0.1%
0.00%0.0%
Q1 2014$897,000
-10.7%
190,719
-4.9%
0.00%0.0%
Q4 2013$1,005,000
-81.8%
200,514
-77.4%
0.00%
-86.7%
Q3 2013$5,513,000
+34.7%
886,363
-1.7%
0.02%
+25.0%
Q2 2013$4,094,000901,8460.01%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q2 2018
NameSharesValueWeighting ↓
Redmile Group, LLC 15,978,580$268,121,0009.11%
BVF INC/IL 4,672,195$78,399,0007.65%
First Light Asset Management, LLC 2,391,575$40,131,0006.25%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 694,500$11,647,0004.47%
Copernicus Capital Management, LLC 286,797$4,812,0003.49%
PACIFIC VIEW ASSET MANAGEMENT, LLC 225,511$3,784,0003.00%
SECTORAL ASSET MANAGEMENT INC 1,566,477$26,285,0002.94%
X-Square Capital, LLC 173,802$2,917,0002.18%
DRIEHAUS CAPITAL MANAGEMENT LLC 2,618,654$43,941,0001.48%
Birchview Capital, LP 128,000$2,148,0001.46%
View complete list of ARRAY BIOPHARMA INC shareholders